New pharmacological options for treating advanced Parkinson's disease.
about
Dopaminergic Neurons Respond to Iron-Induced Oxidative Stress by Modulating Lipid Acylation and Deacylation Cycles.NMDARs in neurological diseases: a potential therapeutic target.Slowness in Movement Initiation is Associated with Proactive Inhibitory Network Dysfunction in Parkinson's Disease.Evaluating and Managing Sleep Disorders in the Parkinson's Disease Clinic.A neurorestorative approach to Parkinson's disease.Evaluation of levodopa and carbidopa antioxidant activity in normal human lymphocytes in vitro: implication for oxidative stress in Parkinson's disease.
P2860
New pharmacological options for treating advanced Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
New pharmacological options for treating advanced Parkinson's disease.
@en
type
label
New pharmacological options for treating advanced Parkinson's disease.
@en
prefLabel
New pharmacological options for treating advanced Parkinson's disease.
@en
P2093
P1476
New pharmacological options for treating advanced Parkinson's disease.
@en
P2093
Caroline Moreau
Ioav Cabantchik
Kathy Dujardin
Regis Bordet
P304
P356
10.1016/J.CLINTHERA.2013.08.011
P577
2013-09-05T00:00:00Z